Institute Affiliations


All Publications


  • AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes. Nature methods Luebeck, J., Liefeld, T., Wong, I. T., Huang, E., Kim, F., Dameracharla, B., Chan, M., Ahuja, R., Fetter, K., Khatri, D., Zhu, K., Tabor, T., Schreyer, D., Prasad, G., Gnanasekar, A., Raeisi Dehkordi, S., Spandau, S., Adamaszek, M., Kenkre, R., Agashe, T., Torvi, D., Giurgiu-Kraljič, M., Kim, S., Kim, H., Bailey, P., Verhaak, R. G., Deshpande, V., Reich, M., Mischel, P. S., Mesirov, J. P., Bafna, V. 2026

    Abstract

    Here we present AmpliconSuite, a toolkit for focal amplification analysis from cancer whole-genome sequencing that identifies extrachromosomal DNA (ecDNA), breakage-fusion-bridges and other amplification modes. Its ecContext module categorizes ecDNA structures to understand formation mechanisms. Validation across 175 metaphase fluorescence in situ hybridization-probed genes in 72 models demonstrated accurate predictions. Analysis of 6,506 patient pan-cancer samples revealed ecDNA-mediated oncogene co-amplification preferences. To democratize data sharing, we created AmpliconRepository, a community-contributable platform, enabling investigation of results across >15,000 publicly hosted samples.

    View details for DOI 10.1038/s41592-026-03264-x

    View details for PubMedID 42888240

    View details for PubMedCentralID 5334176

  • Micronuclear ecDNA constrains tumor cell fitness and is associated with favorable patient survival. Nature genetics Brückner, L., Xu, R., Tang, J., Gnanasekar, A., Herrmann, A., Wong, I. T., Zhang, S., Tu, F., Pilon, M., Kukalev, A., Pardon, K., Sidorova, O., Atta, J., Yu, Q., Montuori, G., Pradella, D., Ilić, M., Suina, K., Novais-Cruz, M., Kaltenbach, S., Treue, D., Giurgiu-Kraljič, M., Herzog, S., Hollinger, A. S., Wittstruck, N., Fernandez, M., Wolozyn, N., Becker, F., Louma, V. R., Yan, X., Schmargon, R., Dörr, J. R., Gamlin, D., Lehmann, A., Gürgen, D., Richter, M., Dubois, F., Simeoni, F., Pennycook, B. R., Hamilton, A., Lindemann, R. K., Dawes, C., Balmus, G., Hero, B., Fischer, M., Bafna, V., Verhaak, R., Wahl, G., Liu, Y., Koche, R. P., Papathanasiou, S., Medema, R., Spanjaard, B., Ventura, A., Pombo, A., Huang, W., Scheer, M., Werner, B., Chang, H. Y., Mischel, P. S., Henssen, A. G. 2026

    Abstract

    Extrachromosomal DNA (ecDNA) contributes to cancer genome instability by enabling high-copy oncogene amplification and genetic intratumoral heterogeneity. Micronuclei (MNs) are common in chromosomally unstable cancers, yet their role in ecDNA-driven tumors remains unclear. Here we investigate how ecDNA damage, mitotic segregation and MN formation are linked. We find that ecDNAs are a major source of MNs following their damage, particularly under replication stress. Replication stress promotes mitotic ecDNA clustering, asymmetric inheritance, mis-segregation into MNs and reduced transcriptional output. Single-MN sequencing reveals that multiple distinct ecDNA species coalesce within individual MNs. Cells inheriting ecDNA+ MNs display impaired proliferative capacity and are more likely to undergo cell death. In patients with MYCN-amplified neuroblastoma, higher frequencies of ecDNA+ MNs at diagnosis are associated with improved overall survival. Together, these findings identify ecDNA mis-segregation as a mechanism that limits tumor fitness, highlighting mitotic ecDNA retention as a potential therapeutic vulnerability.

    View details for DOI 10.1038/s41588-026-02782-w

    View details for PubMedID 42864499

    View details for PubMedCentralID 11549044

  • scAmp enables focal gene amplification analysis from single-cell data. Nature communications Jones, M. G., Weiser, N. E., Hung, K. L., Yan, X., Agarwal, S., Luebeck, J., Gnanasekar, A., Zhang, S., Wong, I. T., Tang, J., Howitt, B. E., Curtis, E. J., Yu, K., Rose, J. C., Kraft, K., Valiollah Pour Amiri, V., Satpathy, L., Bafna, V., Mischel, P. S., Chang, H. Y. 2026; 17 (1)

    Abstract

    Oncogene amplification on extrachromosomal DNA is a common driver of tumor progression and is associated with acquired drug resistance and poor patient survival. While bulk whole genome sequencing studies have revealed the landscape of genes amplified on extrachromosomal DNA in tumors, it remains challenging to study the subclonal heterogeneity and functional (e.g., transcriptomic) consequences of extrachromosomal DNA on tumors. To address this, we introduce scAmp: a probabilistic algorithm for detecting and analyzing extrachromosomal DNA from single-cell datasets. Using well-characterized cell lines, we demonstrate that scAmp has improved specificity over bulk genome sequencing in predicting extrachromosomal DNA status and can resolve the status of chromosomal amplifications that were historically extrachromosomal. We further showcase scAmp by analyzing 73 patient tumors profiled with single-cell assay for transposase-accessible chromatin by sequencing, where we characterize the subclonal evolution of subclones with extrachromosomal DNA and identify the effect of these amplifications on the chromatin accessibility landscape of cancer cells. Finally, we provide proof-of-concept analyses that scAmp aids in the detection of extrachromosomal DNA from clinical histopathology assays. Together, we anticipate that scAmp will broadly enable further studies - both retrospective and prospective - that dissect critical questions of how extrachromosomal DNAs affect cancer cells and the tumors in which they reside.

    View details for DOI 10.1038/s41467-026-76417-3

    View details for PubMedID 42706270

    View details for PubMedCentralID PMC13550473

  • Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer Zhang, S., Wang, Y., Watkins, T. B., Yan, X., Gnanasekar, A., Tang, J., Wong, I. T., Chang, H. Y., Mischel, P. S. AMER ASSOC CANCER RESEARCH. 2026
  • Genetic elements promote retention of extrachromosomal DNA in cancer cells. Nature Sankar, V., Hung, K. L., Gnanasekar, A., Wong, I. T., Shi, Q., Kraft, K., Jones, M. G., He, B. J., Yan, X., Belk, J. A., Liu, K. J., Agarwal, S., Wang, S. K., Henssen, A. G., Mischel, P. S., Chang, H. Y. 2025

    Abstract

    Extrachromosomal DNA (ecDNA) is a prevalent and devastating form of oncogene amplification in cancer1,2. Circular megabase-sized ecDNAs lack centromeres, stochastically segregate during cell division3-6 and persist over many generations. It has been more than 40 years since ecDNAs were first observed to hitchhike on mitotic chromosomes into daughter cell nuclei, but the mechanism underlying this process remains unclear3,7. Here we identify a family of human genomic elements, termed retention elements, that tether episomes to mitotic chromosomes to increase ecDNA transmission to daughter cells. Using Retain-seq, a genome-scale assay that we developed, we reveal thousands of human retention elements that confer generational persistence to heterologous episomes. Retention elements comprise a select set of CpG-rich gene promoters and act additively. Live-cell imaging and chromosome conformation capture show that retention elements physically interact with mitotic chromosomes at regions that are mitotically bookmarked by transcription factors and chromatin proteins. This activity intermolecularly recapitulates promoter-enhancer interactions. Multiple retention elements are co-amplified with oncogenes on individual ecDNAs in human cancers and shape their sizes and structures. CpG-rich retention elements are focally hypomethylated. Targeted cytosine methylation abrogates retention activity and leads to ecDNA loss, which suggests that methylation-sensitive interactions modulate episomal DNA retention. These results highlight the DNA elements and regulatory logic of mitotic ecDNA retention. Amplifications of retention elements promote the maintenance of oncogenic ecDNA across generations of cancer cells, and reveal the principles of episome immortality intrinsic to the human genome.

    View details for DOI 10.1038/s41586-025-09764-8

    View details for PubMedID 41261124

    View details for PubMedCentralID 9470669

  • Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity. Nature communications Raeisi Dehkordi, S., Wong, I. T., Ni, J., Luebeck, J., Zhu, K., Prasad, G., Krockenberger, L., Xu, G., Chowdhury, B., Rajkumar, U., Caplin, A., Muliaditan, D., Gnanasekar, A., Coruh, C., Jin, Q., Turner, K., Teo, S. X., Pang, A. W., Alexandrov, L. B., Chua, C. E., Furnari, F. B., Maciejowski, J., Paulson, T. G., Law, J. A., Chang, H. Y., Yue, F., DasGupta, R., Zhao, J., Mischel, P. S., Bafna, V. 2025; 16 (1): 1497

    Abstract

    Oncogene amplification is a key driver of cancer pathogenesis. Both breakage fusion bridge (BFB) cycles and extrachromosomal DNA (ecDNA) can lead to high oncogene copy numbers, but the impact of BFB amplifications on intratumoral heterogeneity, treatment response, and patient survival remains poorly understood due to detection challenges with DNA sequencing. We introduce an algorithm, OM2BFB, designed to detect and reconstruct BFB amplifications using optical genome mapping (OGM). OM2BFB demonstrates high precision (>93%) and recall (92%) in identifying BFB amplifications across cancer cell lines, patient-derived xenograft models, and primary tumors. Comparisons using OGM reveal that BFB detection with our AmpliconSuite toolkit for short-read sequencing also achieves high precision, though with reduced sensitivity. We identify 371 BFB events through whole genome sequencing of 2557 primary tumors and cancer cell lines. BFB amplifications are prevalent in cervical, head and neck, lung, and esophageal cancers, but rare in brain cancers. Genes amplified through BFB exhibit lower expression variance, with limited potential for regulatory adaptation compared to ecDNA-amplified genes. Tumors with BFB amplifications (BFB(+)) show reduced structural heterogeneity in amplicons and delayed resistance onset relative to ecDNA(+) tumors. These findings highlight ecDNA and BFB amplifications as distinct oncogene amplification mechanisms with differing biological characteristics, suggesting distinct avenues for therapeutic intervention.

    View details for DOI 10.1038/s41467-025-56670-8

    View details for PubMedID 39929823

    View details for PubMedCentralID PMC11811125

  • Coordinated inheritance of extrachromosomal DNAs in cancer cells. Nature Hung, K. L., Jones, M. G., Wong, I. T., Curtis, E. J., Lange, J. T., He, B. J., Luebeck, J., Schmargon, R., Scanu, E., Bruckner, L., Yan, X., Li, R., Gnanasekar, A., Chamorro Gonzalez, R., Belk, J. A., Liu, Z., Melillo, B., Bafna, V., Dorr, J. R., Werner, B., Huang, W., Cravatt, B. F., Henssen, A. G., Mischel, P. S., Chang, H. Y. 2024; 635 (8037): 201-209

    Abstract

    The chromosomal theory of inheritance dictates that genes on the same chromosome segregate together while genes on different chromosomes assort independently1. Extrachromosomal DNAs (ecDNAs) are common in cancer and drive oncogene amplification, dysregulated gene expression and intratumoural heterogeneity through random segregation during cell division2,3. Distinct ecDNA sequences, termed ecDNA species, can co-exist to facilitate intermolecular cooperation in cancer cells4. How multiple ecDNA species within a tumour cell are assorted and maintained across somatic cell generations is unclear. Here we show that cooperative ecDNA species are coordinately inherited through mitotic co-segregation. Imaging and single-cell analyses show that multiple ecDNAs encoding distinct oncogenes co-occur and are correlated in copy number in human cancer cells. ecDNA species are coordinately segregated asymmetrically during mitosis, resulting in daughter cells with simultaneous copy-number gains in multiple ecDNA species before any selection. Intermolecular proximity and active transcription at the start of mitosis facilitate the coordinated segregation of ecDNA species, and transcription inhibition reduces co-segregation. Computational modelling reveals the quantitative principles of ecDNA co-segregation and co-selection, predicting their observed distributions in cancer cells. Coordinated inheritance of ecDNAs enables co-amplification of specialized ecDNAs containing only enhancer elements and guides therapeutic strategies to jointly deplete cooperating ecDNA oncogenes. Coordinated inheritance of ecDNAs confers stability to oncogene cooperation and novel gene regulatory circuits, allowing winning combinations of epigenetic states to be transmitted across cell generations.

    View details for DOI 10.1038/s41586-024-07861-8

    View details for PubMedID 39506152